These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18957056)

  • 1. Synergistic interaction between trifluorothymidine and docetaxel is sequence dependent.
    Bijnsdorp IV; Kruyt FA; Gokoel S; Fukushima M; Peters GJ
    Cancer Sci; 2008 Nov; 99(11):2302-8. PubMed ID: 18957056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidine.
    Temmink OH; Hoebe EK; Fukushima M; Peters GJ
    Eur J Cancer; 2007 Jan; 43(1):175-83. PubMed ID: 17049227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.
    Azijli K; van Roosmalen IA; Smit J; Pillai S; Fukushima M; de Jong S; Peters GJ; Bijnsdorp IV; Kruyt FA
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1273-83. PubMed ID: 24744163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
    Temmink OH; Hoogeland MF; Fukushima M; Peters GJ
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):171-9. PubMed ID: 16010590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines.
    Bijnsdorp IV; Kruyt FA; Fukushima M; Smid K; Gokoel S; Peters GJ
    Cancer Sci; 2010 Feb; 101(2):440-7. PubMed ID: 19886911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells.
    Bijnsdorp IV; Peters GJ; Temmink OH; Fukushima M; Kruyt FA
    Int J Cancer; 2010 May; 126(10):2457-68. PubMed ID: 19816940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.
    Temmink OH; Hoebe EK; van der Born K; Ackland SP; Fukushima M; Peters GJ
    Br J Cancer; 2007 Jan; 96(2):231-40. PubMed ID: 17242697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells.
    Park HS; Hong SK; Oh MM; Yoon CY; Jeong SJ; Byun SS; Cheon J; Lee SE; Moon du G
    Anticancer Res; 2014 Jul; 34(7):3457-68. PubMed ID: 24982354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models.
    Tesei A; Leonetti C; Zupi G; Scarsella M; Brigliadori G; Ulivi P; Fabbri F; Arienti C; Amadori D; Passardi A; Silvestrini R; Zoli W
    J Cell Mol Med; 2011 Feb; 15(2):316-26. PubMed ID: 20015197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction between sunitinib and docetaxel is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation.
    Pan F; Tian J; Zhang X; Zhang Y; Pan Y
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1397-408. PubMed ID: 21796416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma.
    Saigal B; Glisson BS; Johnson FM
    Anticancer Drugs; 2008 Jun; 19(5):465-75. PubMed ID: 18418213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.
    Azrak RG; Frank CL; Ling X; Slocum HK; Li F; Foster BA; Rustum YM
    Mol Cancer Ther; 2006 Oct; 5(10):2540-8. PubMed ID: 17041098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic enhancement of cancer therapy using a combination of ceramide and docetaxel.
    Feng LX; Li M; Liu YJ; Yang SM; Zhang N
    Int J Mol Sci; 2014 Mar; 15(3):4201-20. PubMed ID: 24619193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
    Pegram MD; Konecny GE; O'Callaghan C; Beryt M; Pietras R; Slamon DJ
    J Natl Cancer Inst; 2004 May; 96(10):739-49. PubMed ID: 15150302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trifluorothymidine induces cell death independently of p53.
    Bijnsdorp IV; Kruyt FA; Fukushima M; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):699-703. PubMed ID: 18600528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells.
    Temmink OH; de Bruin M; Comijn EM; Fukushima M; Peters GJ
    Anticancer Drugs; 2005 Mar; 16(3):285-92. PubMed ID: 15711180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells.
    Temmink OH; Prins HJ; van Gelderop E; Peters GJ
    Br J Cancer; 2007 Jan; 96(1):61-6. PubMed ID: 17179993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB.
    Lee SY; Cho JS; Yuk DY; Moon DC; Jung JK; Yoo HS; Lee YM; Han SB; Oh KW; Hong JT
    J Pharmacol Sci; 2009 Oct; 111(2):124-36. PubMed ID: 19834284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells.
    Orlandi P; Gentile D; Banchi M; Cucchiara F; Di Desidero T; Cremolini C; Moretto R; Falcone A; Bocci G
    Invest New Drugs; 2020 Feb; 38(1):92-98. PubMed ID: 31154566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure-dependent incorporation of trifluridine into DNA of tumors and white blood cells in tumor-bearing mouse.
    Yamashita F; Komoto I; Oka H; Kuwata K; Takeuchi M; Nakagawa F; Yoshisue K; Chiba M
    Cancer Chemother Pharmacol; 2015 Aug; 76(2):325-33. PubMed ID: 26084259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.